Immunomodulatory activity of 4-(Benzyloxy)phenol facilitates intracellular mycobacterial clearance through p53 mediated IL-35 signaling dependent JAK1/STAT3 pathway in human macrophages.

Publication date: Jun 26, 2025

Mycobacterium tuberculosis (M. tuberculosis), the causative agent of tuberculosis (TB), modulates host immune responses by regulating various cytokines. Precise regulation of these cytokines renders the host pathogen-free, whereas their dysregulation increases the susceptibility to infection. Hence, induction of host protective cytokines using immunomodulators to promote M. tuberculosis clearance has a rewarding impact in the context of TB treatment. This study explored the immunomodulatory activity of 4-(Benzyloxy)phenol (4-BOP) in mycobacteria infected differentiated THP-1 cells through IL-35 (an anti-inflammatory cytokine) production. Initially, we observed an increased mRNA and protein level expression of IL-35 and its cognate receptor upon 4-BOP treatment in mycobacteria-infected dTHP-1 cells. IL-35 receptor activation further led to phosphorylation of JAK1/STAT3, culminating in increased phagosome-lysosome fusion through elevation of intracellular Ca level. Blocking IL-35 receptors using siRNA-mediated approach against IL-12Rβ2 and gp130 or the JAK1/STAT3 associated signaling with specific inhibitors like Baricitinib and Stattic promoted the intracellular mycobacterial survival by compromising Ca-phagosome-lysosome fusion pathway. Further, we identified a direct regulatory role of p53 (known to be activated by 4-BOP) on IL-35 production, and inhibition of p53 using PFT-α surprisingly abrogated the IL-35 mediated signaling axis. Collectively, our results demonstrated a host defensive role of 4-BOP-induced Il-35 signaling in mycobacteria-infected dTHP-1 cells through the JAK1/STAT3 mediated Ca-phagosome-lysosome fusion pathway. These results suggest that 4-BOP may serve as a potent HDT candidate for regulating inflammation and enhancing host defense in TB infection.

Concepts Keywords
Benzyloxyphenol 4-BOP
Dthp Ca2+
Mycobacteria Humans
Rewarding IL-35
Tuberculosis Immunologic Factors
Immunologic Factors
interleukin-35, human
Interleukins
Interleukins
JAK1 protein, human
JAK1/STAT3
Janus Kinase 1
Janus Kinase 1
Macrophages
Mycobacteria
Mycobacterium tuberculosis
Phagosome-lysosome fusion
Phenols
Phenols
Signal Transduction
STAT3 protein, human
STAT3 Transcription Factor
STAT3 Transcription Factor
THP-1 Cells
Tuberculosis

Semantics

Type Source Name
drug DRUGBANK Monobenzone
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease IDO host
disease IDO pathogen
disease IDO susceptibility
disease MESH infection
disease IDO production
disease IDO protein
drug DRUGBANK Baricitinib
disease IDO role
drug DRUGBANK Bentiromide
disease MESH inflammation
pathway REACTOME Signal Transduction

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *